A clinical prediction rule for ambulation outcomes after traumatic spinal cord injury: a longitudinal cohort study - The Lancet
Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review - The Lancet Oncology
Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes - The Lancet Infectious Diseases
Clinical evaluation of the BioFire Global Fever Panel for the identification of malaria, leptospirosis, chikungunya, and dengue from whole blood: a prospective, multicentre, cross-sectional diagnostic accuracy study - The Lancet Infectious Diseases
A minimal common outcome measure set for COVID-19 clinical research - The Lancet Infectious Diseases
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial - The Lancet Regional Health – Americas
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study - The Lancet Respiratory Medicine
Lancet eBooks
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study - The Lancet Respiratory Medicine
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases
The Lancet: Journal Homepage
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases
Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial - The Lancet
Rapid triage for COVID-19 using routine clinical data for patients attending hospital: development and prospective validation of an artificial intelligence screening test - The Lancet Digital Health
Migraine: integrated approaches to clinical management and emerging treatments - The Lancet
Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: a modelling study - The Lancet Public Health
Patient-reported wellbeing and clinical disease measures over time captured by multivariate trajectories of disease activity in individuals with juvenile idiopathic arthritis in the UK: a multicentre prospective longitudinal study - The Lancet
Immunogenicity induced by the use of alternative vaccine platforms to deal with vaccine shortages in a low- to middle-income country: Results of two randomized clinical trials - The Lancet Regional Health –
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial - The Lancet
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial - The Lancet Respiratory Medicine
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial - The Lancet Global Health
Graphical abstracts
Etrolizumab for ulcerative colitis: beyond what meets the eye - The Lancet Gastroenterology & Hepatology
Clinical and virological data of the first cases of COVID-19 in Europe: a case series - The Lancet Infectious Diseases
The Lancet Commission on the future of care and clinical research in autism - The Lancet
